Skip to main content

Table 1 Baseline Patient Characteristics

From: Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

  Urethral Sparing IMRT Standard IMRT Total Cohort
# of patients 8 8 16
Age (mean ± SD) 63.9 ± 7.3 64.5 ± 7.1 64.21 ± 6.9
Pretreatment PSA (ng/mL) 8.1 ± 1.3 7.4 ± 1.5 7.74 ± 0.62
# positive cores (mean ± SD) 1.6 ± 0.7 1.1 ± 0.4 1.4 ± 0.6
EPIC Urinary Domain Summary score (mean ± SD) 86.9 ± 13.4 81.6 ± 16.5 84.3 ± 14.8
EPIC Bowel Domain Summary score (mean ± SD) 96.6 ± 5.1 92.5 ± 7.1 94.5 ± 6.4
EPIC Sexual Domain Summary score (mean ± SD) 52.5 ± 12.4 47.4 ± 32.8 50.0 ± 24.1
EPIC Hormonal Domain Summary score (mean ± SD) 89.3 ± 15.3 90.6 ± 9.8 90.0 ± 12.4
Satisfaction Score (mean ± SD) 85.7 ± 19.7 85.0 ± 13.7 85.4 ± 16.7